ZIM
HAE icon

Zacks Investment Management’s Haemonetics HAE Stock Holding History

Zacks Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,146
Closed -$1.28M – 732
2025
Q1 		$1.28M Buy
20,146
+703
+4% +$47.8K 0.01% 379
2024
Q4 		$1.52M Buy
19,443
+2,522
+15% +$203K 0.01% 369
2024
Q3 		$1.36M Buy
16,921
+1,740
+11% +$141K 0.01% 381
2024
Q2 		$1.26M Buy
15,181
+1,473
+11% +$130K 0.01% 343
2024
Q1 		$1.17M Buy
13,708
+2,884
+27% +$226K 0.01% 385
2023
Q4 		$926K Sell
10,824
-1,102
-9% -$95.3K 0.01% 386
2023
Q3 		$1.07M Buy
11,926
+993
+9% +$88.7K 0.01% 364
2023
Q2 		$931K Buy
+10,933
New +$924K 0.01% 384
2020
Q4 		– Sell
-7,154
Closed -$624K – 544
2020
Q3 		$624K Sell
7,154
-5,740
-45% -$502K 0.01% 379
2020
Q2 		$1.16M Sell
12,894
-1,668
-11% -$168K 0.03% 278
2020
Q1 		$1.45M Sell
14,562
-670
-4% -$72.7K 0.04% 242
2019
Q4 		$1.75M Sell
15,232
-2,663
-15% -$322K 0.03% 296
2019
Q3 		$2.26M Buy
17,895
+7,906
+79% +$1M 0.05% 234
2019
Q2 		$1.2M Buy
+9,989
New +$983K 0.02% 373
2014
Q1 		– Sell
-13,246
Closed -$558K – 713
2013
Q4 		$558K Sell
13,246
-7,514
-36% -$309K 0.02% 347
2013
Q3 		$828K Buy
20,760
+1,088
+6% +$45.6K 0.04% 249
2013
Q2 		$813K Buy
+19,672
New +$796K 0.04% 247

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Zacks Investment Management's HAE Position: Q2 2025 in Review

Zacks Investment Management sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 20,146 shares — an estimated $1.28M sold.

Zacks Investment Management first reported a position in HAE in Q2 2013 and held it in 17 quarters. The position peaked at $2.26M in Q3 2019. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Zacks Investment Management reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Zacks Investment Management sold 20,146 Haemonetics shares in Q2 2025, an estimated $1.28M.
  • Zacks Investment Management first reported a position in Haemonetics in Q2 2013 and held it in 17 quarters.
  • Zacks Investment Management's Haemonetics position peaked at $2.26M in Q3 2019.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Zacks Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.